ATE112567T1 - Imidazo(4,5-c>pyridine als paf antagonisten. - Google Patents

Imidazo(4,5-c>pyridine als paf antagonisten.

Info

Publication number
ATE112567T1
ATE112567T1 AT91909431T AT91909431T ATE112567T1 AT E112567 T1 ATE112567 T1 AT E112567T1 AT 91909431 T AT91909431 T AT 91909431T AT 91909431 T AT91909431 T AT 91909431T AT E112567 T1 ATE112567 T1 AT E112567T1
Authority
AT
Austria
Prior art keywords
imidazo
pyridine
paf antagonist
paf
antagonist
Prior art date
Application number
AT91909431T
Other languages
German (de)
English (en)
Inventor
Anthony Marfat
James Frederick Eggler
Kevin Cooper
Michael Jonathan Fray
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE112567T1 publication Critical patent/ATE112567T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT91909431T 1990-05-09 1991-05-01 Imidazo(4,5-c>pyridine als paf antagonisten. ATE112567T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52119990A 1990-05-09 1990-05-09

Publications (1)

Publication Number Publication Date
ATE112567T1 true ATE112567T1 (de) 1994-10-15

Family

ID=24075786

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91909431T ATE112567T1 (de) 1990-05-09 1991-05-01 Imidazo(4,5-c>pyridine als paf antagonisten.

Country Status (28)

Country Link
EP (1) EP0533695B1 (en, 2012)
JP (1) JPH0678340B2 (en, 2012)
CN (1) CN1057839A (en, 2012)
AP (1) AP224A (en, 2012)
AT (1) ATE112567T1 (en, 2012)
AU (1) AU642265B2 (en, 2012)
BG (1) BG97059A (en, 2012)
BR (1) BR9106433A (en, 2012)
CA (1) CA2080476A1 (en, 2012)
DE (1) DE69104481T2 (en, 2012)
DK (1) DK0533695T3 (en, 2012)
ES (1) ES2061247T3 (en, 2012)
FI (1) FI925053A0 (en, 2012)
GT (1) GT199100031A (en, 2012)
HU (1) HUT62894A (en, 2012)
IE (1) IE911553A1 (en, 2012)
IL (1) IL98075A0 (en, 2012)
MA (1) MA22151A1 (en, 2012)
MY (1) MY105512A (en, 2012)
NO (1) NO924290D0 (en, 2012)
NZ (1) NZ238089A (en, 2012)
PE (1) PE26691A1 (en, 2012)
PT (1) PT97616A (en, 2012)
RO (1) RO109450B1 (en, 2012)
TW (1) TW205549B (en, 2012)
WO (1) WO1991017163A1 (en, 2012)
YU (1) YU81191A (en, 2012)
ZA (1) ZA913497B (en, 2012)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102997D0 (en) * 1991-02-13 1991-03-27 Pfizer Ltd Therapeutic agents
AU5016793A (en) * 1992-08-20 1994-03-15 Cytomed, Inc Dual functional anti-inflammatory and immunosuppressive agents
US6372770B1 (en) 1994-10-12 2002-04-16 Euro-Celtique, S.A. Benzoxazoles
CN1308622A (zh) * 1998-05-12 2001-08-15 美国家用产品公司 用于治疗胰岛素抗性和高血糖的联苯基氧代－乙酸
US6232322B1 (en) 1998-05-12 2001-05-15 American Home Products Corporation Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6310081B1 (en) 1999-05-10 2001-10-30 American Home Products Corporation Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
JP2016537398A (ja) * 2013-09-13 2016-12-01 コーテンドー エービー（ピーユービーエル）Ｃｏｒｔｅｎｄｏ Ａｂ（Ｐｕｂｌ） 新規なチトクロムｐ４５０阻害剤及びこれらの使用方法
CN105348182B (zh) * 2014-08-24 2018-04-13 复旦大学 2‑烷氧基苯甲酰芳胺类化合物及其药物用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8401486A1 (es) * 1981-11-10 1983-12-01 Wellcome Found Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.
GB8804439D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Dihydropyridines
GB8822170D0 (en) * 1988-09-21 1988-10-26 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
FI925053L (fi) 1992-11-06
RO109450B1 (ro) 1995-02-28
HUT62894A (en) 1993-06-28
MA22151A1 (fr) 1991-12-31
EP0533695B1 (en) 1994-10-05
WO1991017163A1 (en) 1991-11-14
GT199100031A (es) 1992-10-30
IE911553A1 (en) 1991-11-20
HU9203496D0 (en) 1993-01-28
IL98075A0 (en) 1992-06-21
ZA913497B (en) 1992-12-30
JPH05505619A (ja) 1993-08-19
MY105512A (en) 1994-10-31
DK0533695T3 (da) 1995-01-09
AP224A (en) 1992-10-27
AU7867191A (en) 1991-11-27
PE26691A1 (es) 1991-10-21
AP9100259A0 (en) 1991-07-31
EP0533695A1 (en) 1993-03-31
CA2080476A1 (en) 1991-11-10
CN1057839A (zh) 1992-01-15
BR9106433A (pt) 1993-05-04
DE69104481T2 (de) 1995-02-09
FI925053A7 (fi) 1992-11-06
YU81191A (sh) 1994-06-10
TW205549B (en, 2012) 1993-05-11
NO924290L (no) 1992-11-06
NO924290D0 (no) 1992-11-06
NZ238089A (en) 1992-10-28
JPH0678340B2 (ja) 1994-10-05
PT97616A (pt) 1992-03-31
BG97059A (bg) 1993-12-24
DE69104481D1 (de) 1994-11-10
AU642265B2 (en) 1993-10-14
ES2061247T3 (es) 1994-12-01
FI925053A0 (fi) 1992-11-06

Similar Documents

Publication Publication Date Title
DE59100656D1 (de) Bohrfutter.
DE59101925D1 (de) Bohrfutter.
DE59104722D1 (de) Drehmaschine.
FI915920L (fi) Serotoninantagonister.
FI912409L (fi) Bicykliska 1-aza-cykloalkaner.
ATE121741T1 (de) Piperidinyl-benzimidazole als antihistaminica.
FI913048A0 (fi) Bicykliska heterocykliska foereningar.
FI922143A7 (fi) Muscarinreceptorantagonister.
DE3877491D1 (de) Polysaccharid-/perfluoralkyl-komplexverbindungen.
ITTO910865A1 (it) Composti triciclici.
FI925054A7 (fi) Imidatsopyridiini-PAF-antagonisteja
ATE116980T1 (de) Verbesserungen an leukotrien-antagonieten.
FI922045A7 (fi) Yhdistetty rakenne, erityisesti rakentamista varten
ATE112567T1 (de) Imidazo(4,5-c>pyridine als paf antagonisten.
FI913182A0 (fi) Tricykliska foereningar innehaollande heteroatomer.
ATE50259T1 (de) 1,6-naphthyridin-2(1h)-one brauchbar als kardiotonika.
NO895217L (no) Substituerte pyrido(2,3-d)pyrimidiner.
FI900873A7 (fi) Foerfarande i samband med impedansgivare i radiosonder.
FI941377L (fi) Neuroleptisiä 2-substituoituja perhydro-1-H-pyrido/1,2-a/-pyratsiineja
IT234656Y1 (it) Gruppo costruttivo per cassetti.
FI910977L (fi) Foerbaettringar i samband med kalander- och praeglingsvalsar.
FI914503L (fi) 2-(4-piperidinyl)-1h-pyrido(4,3-b) indol-1-oner och deras beslaektade foereningar, mellanprodukter och foerfarande foer deras framstaellning.
DOP1993004907A (es) Nuevos agentes nematicidas.
FI930108A7 (fi) Imidatsopyridiini-PAF-antagonisteja
FI922346A7 (fi) Muscarinreceptorantagonister.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee